End Point Measures
postreperfusion syndrome, liver IRI
The primary end point was defined as the difference between the 2 study arms in peak serum aspartate aminotransferase (AST) levels within the first 72 hours after graft reperfusion, an accepted clinical surrogate of liver IRI that correlates with patient and graft survival and postreperfusion liver histological assessment.Secondary end points included the frequencies of postreperfusion syndrome,